Related references
Note: Only part of the references are listed.Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
Chia Chi Sun et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index
Barry S. Skikne et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Hepcidin and Disorders of Iron Metabolism
Tomas Ganz et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia
Susanne van Santen et al.
ARTHRITIS AND RHEUMATISM (2011)
Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation
Todd S. Perlstein et al.
BLOOD (2011)
Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients
Victoria A. Kumar et al.
JOURNAL OF NEPHROLOGY (2011)
Proinflammatory state, hepcidin, and anemia in older persons
Luigi Ferrucci et al.
BLOOD (2010)
Detection, evaluation, and management of iron-restricted erythropoiesis
Lawrence Tim Goodnough et al.
BLOOD (2010)
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
Soken-Nakazawa J. Song et al.
BLOOD (2010)
Anemia of Inflammation
Cindy N. Roy
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2010)
Treatment with Infliximab plus Methotrexate Improves Anemia in Patients with Rheumatoid Arthritis Independent of Improvement in Other Clinical Outcome Measures-A Pooled Analysis from Three Large, Multicenter, Double-Blind, Randomized Clinical Trials
Mittie K. Doyle et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
Mark C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
